OST
Open Science Tracker
Home
Search
Journals
Fields
Analytics
API
Research Papers
25 of 261 papers
CSV
Excel
All Years
All Papers
High Transparency
Medium Transparency
Low Transparency
Search
Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Stereotactic body radiotherapy in lung cancer: a contemporary review.
Csiki E
;
Simon M
;
Papp J
;
Barabás M
;
Mikáczó J
;
Gál K
;
Sipos D
;
Kovács Á.
Pathol Oncol Res
(Unknown)
Published:
2024
2/6 Transparent
PMC
DOI
LINAC-based SBRT in treating early-stage NSCLC patients-single institution experience and survival data analysis.
Kovács Á
;
Trási K
;
Barabás M
;
Gál K
;
Csiki E
;
Sipos D
;
Papp J
;
Simon M.
Pathol Oncol Res
(Unknown)
Published:
2024
2/6 Transparent
PMC
DOI
Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment.
Dai J
;
Jiang Y
;
Hu H
;
Zhang S
;
Chen Y.
Pathol Oncol Res
(Unknown)
Published:
2024
2/6 Transparent
PMC
DOI
Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity in oral squamous cell…
Sakurai S
;
Ishida Y
;
Shintani T
;
Yamasaki S
;
Matsui K
;
Hamana T
;
Nobumoto T
;
Yanamoto S
;
Hayashido Y.
Pathol Oncol Res
(Unknown)
Published:
2024
2/6 Transparent
PMC
DOI
Analysis of HIF-1α expression and genetic polymorphisms in human clear cell renal cell carcinoma.
Vargova D
;
Kolková Z
;
Dargaj J
;
Bris L
;
Luptak J
;
Dankova Z
;
Franova S
;
Svihra J
;
Slávik P
;
Sutovska M.
Pathol Oncol Res
(Unknown)
Published:
2023
4/6 Transparent
Data
Funding Declared
PMC
DOI
Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia.
Hasanova A
;
Asadov C
;
Karimova N
;
Shirinova A
;
Aliyeva G
;
Alimirzoyeva Z.
Pathol Oncol Res
(Unknown)
Published:
2023
3/6 Transparent
Funding Declared
PMC
DOI
Quantitative analysis of endobronchial elastography combined with serum tumour markers of lung cancer in the diagnosis …
Wang Z
;
Li P
;
Bai J
;
Liu Y
;
Jiao G.
Pathol Oncol Res
(Unknown)
Published:
2023
3/6 Transparent
Funding Declared
PMC
DOI
Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14).
Ceglédi A
;
Csukly Z
;
Fekete M
;
Kozma A
;
Szemlaky Z
;
Andrikovics H
;
Mikala G.
Pathol Oncol Res
(Unknown)
Published:
2023
3/6 Transparent
Funding Declared
PMC
DOI
Recent advances and future directions in etiopathogenesis and mechanisms of reactive oxygen species in cancer treatment.
Verma P
;
Rishi B
;
George NG
;
Kushwaha N
;
Dhandha H
;
Kaur M
;
Jain A
;
Jain A
;
Chaudhry S
;
Singh A
;
Siraj F
;
Misra A.
Pathol Oncol Res
(Unknown)
Published:
2023
2/6 Transparent
PMC
DOI
A new perspective on the proper timing of radiotherapy during CDK4/6 inhibitor therapy in patients with "bone-only" met…
Tornyi I
;
Árkosy P
;
Horváth I
;
Furka A.
Pathol Oncol Res
(Unknown)
Published:
2023
2/6 Transparent
PMC
DOI
Commentary: Percutaneous tracheostomy: comparison of three different methods with respect to tracheal cartilage injury …
Klemm E
;
Nowak A.
Pathol Oncol Res
(Unknown)
Published:
2023
2/6 Transparent
PMC
DOI
Active cancer as the main predictor of mortality for COVID-19 in oncology patients in a specialized center.
Villanueva-Cotrina F
;
Velarde J
;
Rodriguez R
;
Bonilla A
;
Laura M
;
Saavedra T
;
Portillo-Alvarez D
;
Bustamante Y
;
Fernandez C
;
Galvez-Nino M.
Pathol Oncol Res
(Unknown)
Published:
2023
2/6 Transparent
PMC
DOI
Patient delay and its clinical significance among head and neck cancer patients in Hungary.
Dános K
;
Horváth A
;
Halász J
;
Tamás L
;
Polony G.
Pathol Oncol Res
(Unknown)
Published:
2023
2/6 Transparent
PMC
DOI
Obesity as a risk factor for multiple myeloma: insight on the role of adipokines.
Tie W
;
Ma T
;
Yi Z
;
Liu J
;
Li Y
;
Bai J
;
Li L
;
Zhang L.
Pathol Oncol Res
(Unknown)
Published:
2023
3/6 Transparent
Funding Declared
PMC
DOI
Influence of the microbiota on the effectiveness and toxicity of oncological therapies, with a focus on chemotherapy.
Cazzaniga M
;
Zonzini GB
;
Di Pierro F
;
Palazzi CM
;
Cardinali M
;
Bertuccioli A.
Pathol Oncol Res
(Unknown)
Published:
2023
2/6 Transparent
PMC
DOI
Wide-field optical coherence tomography for microstructural analysis of key tissue types: a proof-of-concept evaluation.
Rabindran B
;
Corben AD.
Pathol Oncol Res
(Unknown)
Published:
2023
2/6 Transparent
PMC
DOI
Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer.
Chai J
;
Liu X
;
Hu X
;
Wang C.
Pathol Oncol Res
(Unknown)
Published:
2023
2/6 Transparent
PMC
DOI
Grade Group accuracy is improved by extensive prostate biopsy sampling, but unrelated to prostatectomy specimen samplin…
Korpás KL
;
Beke L
;
Varga D
;
Bidiga L
;
Méhes G
;
Molnár S.
Pathol Oncol Res
(Unknown)
Published:
2023
2/6 Transparent
PMC
DOI
CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targ…
Shen L
;
Chen YL
;
Huang CC
;
Shyu YC
;
Seftor REB
;
Seftor EA
;
Hendrix MJC
;
Chien DS
;
Chu YW.
Pathol Oncol Res
(Unknown)
Published:
2023
3/6 Transparent
Funding Declared
PMC
DOI
Association between radiomics features of DCE-MRI and CD8<sup>+</sup> and CD4<sup>+</sup> TILs in advanced gastric canc…
Huang H
;
Li Z
;
Xia Y
;
Zhao Z
;
Wang D
;
Jin H
;
Liu F
;
Yang Y
;
Shen L
;
Lu Z.
Pathol Oncol Res
(Unknown)
Published:
2023
3/6 Transparent
Funding Declared
PMC
DOI
Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer.
Sun J
;
Sun Y
;
Miniderima
;
Wang X.
Pathol Oncol Res
(Unknown)
Published:
2023
3/6 Transparent
Funding Declared
PMC
DOI
Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-ass…
Ceglédi A
;
Dolgos J
;
Fekete M
;
Gopcsa L
;
Várkonyi A
;
Vilimi B
;
Mikala G
;
Bodó I.
Pathol Oncol Res
(Unknown)
Published:
2023
3/6 Transparent
Funding Declared
PMC
DOI
Integrated oxidative stress score for predicting prognosis in stage III gastric cancer undergoing surgery.
Liu YH
;
Meng R
;
Zhu B
;
Zhan QQ
;
Yang X
;
Ding GY
;
Jia CL
;
Liu QY
;
Xu WG.
Pathol Oncol Res
(Unknown)
Published:
2023
3/6 Transparent
Funding Declared
PMC
DOI
Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer.
Vlahović I
;
Rajc J
;
Švagelj I
;
Šolić K
;
Švagelj D.
Pathol Oncol Res
(Unknown)
Published:
2023
2/6 Transparent
PMC
DOI
Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance.
Leeha M
;
Kanokwiroon K
;
Laohawiriyakamol S
;
Thongsuksai P.
Pathol Oncol Res
(Unknown)
Published:
2023
3/6 Transparent
Funding Declared
PMC
DOI
1
2
3
Next